trihexyphenidyl has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weitzman, DO | 1 |
| Rosfnfeld, C | 1 |
| Korenyl, C | 1 |
| Whittier, JR | 1 |
| Critchley, EM | 1 |
| Clark, DB | 1 |
| Wikler, A | 1 |
2 other studies available for trihexyphenidyl and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Quantification of chorea in Huntington's disease by power spectral analysis.
Topics: Adult; Aged; Diazepam; Haloperidol; Humans; Huntington Disease; Mesoridazine; Methods; Middle Aged; | 1976 |
An adult form of acanthocytosis.
Topics: Abetalipoproteinemia; Adult; Ataxia; Diazepam; Female; Haloperidol; Humans; Huntington Disease; Hydr | 1967 |